Northern Trust
SRRA

Northern Trust’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Northern Trust’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-169,937
Closed -$9.35M – 4824
2022
Q2 		$9.35M Buy
169,937
+132,187
+350% +$6.94M ﹤0.01% 2082
2022
Q1 		$1.21M Sell
37,750
-962
-2% -$27.6K ﹤0.01% 3344
2021
Q4 		$842K Sell
38,712
-118
-0.3% -$2.6K ﹤0.01% 3604
2021
Q3 		$851K Buy
38,830
+270
+0.7% +$5.4K ﹤0.01% 3601
2021
Q2 		$750K Buy
38,560
+20,074
+109% +$365K ﹤0.01% 3601
2021
Q1 		$319K Sell
18,486
-13,152
-42% -$208K ﹤0.01% 3961
2020
Q4 		$507K Sell
31,638
-3,842
-11% -$53.4K ﹤0.01% 3722
2020
Q3 		$379K Buy
35,480
+743
+2% +$8.85K ﹤0.01% 3671
2020
Q2 		$421K Buy
+34,737
New +$431K ﹤0.01% 3598

Other funds holding SRRA

HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Northern Trust's SRRA Position: Q3 2022 in Review

Northern Trust sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 169,937 shares — an estimated $9.35M sold.

Northern Trust first reported a position in SRRA in Q2 2020 and held it in 9 quarters. The position peaked at $9.35M in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

  • Northern Trust reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Northern Trust sold 169,937 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $9.35M.
  • Northern Trust first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2020 and held it in 9 quarters.
  • Northern Trust's Sierra Oncology, Inc. Common Stock position peaked at $9.35M in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on Northern Trust's 13F filing for Q3 2022, filed 14 Nov 2022.